Page 135 - Aet News Today

Paxlovid, a Pfizer antiviral awarded FDA emergency authorization in 2021 for treating Covid-19, is now approved for treating adults. Results from a pivotal clinical showed that Paxlovid led to an 86% reduction in Covid-19-related hospitalization or death from any cause compared to a placebo.

The quest to enact local bans has become particularly acute in small towns, like West Wendover, Nevada, and Hobbs, New Mexico, which are situated by borders between states that have restricted abortion and states where laws preserve access.

It shouldn't be so hard for Americans to access healthy foods, said Dr. Elizabeth Klodas, founder of healthy food company Step One Foods, during a Tuesday panel at the MedCity INVEST conference in Chicago. There should be incentives for food companies and better nutrition education for Americans.

During MedCity News’ INVEST conference, CommonSpirit Health CIO Daniel Barchi laid out two critical actions that hospitals can take to help ensure their new technology investments will be worth their time and money. The first is to prioritize scalability, and the second is to involve frontline clinical staff early on in the process.

A panel during the MedCity News INVEST conference discussed what digital health technologies need to do to demonstrate return on investment for payers, providers, and other stakeholders.

There are too many flaws in AI for it to replace physicians, execs said during a Monday panel at the MedCity INVEST conference in Chicago. Instead, it should be used to make physicians' work easier.

We cannot foresee how generative AI will play out, but much like a smartphone with Tiktok, it is only limited by our imaginations and ingenuity.

Experts argued that value-based care is here to stay and will play a major role in the future of healthcare during MedCity's Invest conference in Chicago. A panel of four agreed that the success of value-based care depends on organizational commitment — it’s a quixotic mistake to think these alternative payment models can gain traction overnight.

Yaniv Sneor, the co-founder of Mid Atlantic Bio Angels and part of the Ask the Investor sessions at MedCity INVEST this week, explained what his firm looks for in life science startups.

Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.